Events & Activity
- RGLS:NAQ reported earnings of -0.29 for the period of the year 2024Q1.
- RGLS:NAQ price rises above 50-day moving average to 2.33 at 11:17 BST
- RGLS:NAQ price moved over +5.25% to 2.79
- RGLS:NAQ price rises above 50-day moving average to 2.32 at 11:25 BST
- RGLS:NAQ price falls below 50-day moving average to 2.29 at 11:09 BST
- RGLS:NAQ trading volume exceeds daily average by +15.07%
- RGLS:NAQ price rises above 15-day moving average to 2.36 at 11:53 BST
- RGLS:NAQ price falls below 15-day moving average to 2.38 at 10:48 BST
- RGLS:NAQ price falls below 15-day moving average to 2.40 at 15:08 BST
Key statistics
On Thursday, Regulus Therapeutics Inc (RGLS:NAQ) closed at 2.25, 108.33% above the 52 week low of 1.08 set on Jan 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.26 |
---|---|
High | 2.36 |
Low | 2.20 |
Bid | 2.16 |
Offer | 2.75 |
Previous close | 2.25 |
Average volume | 498.85k |
---|---|
Shares outstanding | 65.47m |
Free float | 64.36m |
P/E (TTM) | -- |
Market cap | 147.30m USD |
EPS (TTM) | -1.59 USD |
Data delayed at least 15 minutes, as of May 09 2024 21:00 BST.
More ▼